Ivrea 1 Cream

Ivrea 1 Cream is primarily used in the management of conditions such as scabies and certain forms of demodicosis. The topical formulation allows targeted delivery of the active ingredient, minimizing systemic absorption and reducing the risk of systemic side effects. Application should be limited to the affected areas, typically once daily for the prescribed duration, generally 2 to 4 weeks depending on clinical response.

Ivrea 1 Cream is contraindicated in patients with known hypersensitivity to Ivermectin or any excipients in the formulation. Caution is advised when applying to large surface areas or damaged skin. Adverse effects are generally mild and may include local irritation, erythema, or pruritus at the application site. Patients should follow healthcare provider instructions closely to ensure optimal therapeutic outcomes and avoid misuse.